Rationale Endocannabinoid, opioid, and dopamine systems interact to exhibit cannabinoid receptor neuromodulation of opioid peptides and D 4 dopamine receptor gene expression in CB 1 -cannabinoid-deficient mouse striatum. Objective Using CB 1 -transgenic mice, we examine primary age-sex influences and interactions on opioid and dopamine system members' gene expression in striatum. 
that respond to a family of eicosanoid mediators referred to as endocannabinoids, notably anandamide and 2-arachidonoylglycerol. The function of the endocannabinoid system includes the retrograde transmission of endocannabinoids and activation of presynaptic CB 1 receptors to regulate neurotransmitter release (Chevaleyre et al. 2006) . CB 1 receptors are highly expressed in the striatum (Herkenham et al. 1991) , and they affect directly or indirectly several functions that involve the basal ganglia (i.e., judgment, memory and reward, and the controls for planning and modulation of movement; Gerdeman et al. 2003; van der Stelt and Di Marzo 2003) . There is a growing body of evidence that the endogenous cannabinoid system might participate in the motivational and dopamine-releasing effects of several drugs of abuse (Basavarajappa and Hungund 2005; Laviolette and Grace 2006; Parolaro et al. 2005) . This may be mediated in part by activation of dopaminergic mesolimbic neurons. For example, stimulation of the CB 1 receptors by the cannabinoid agonist Δ 9 -THC caused dopamine release and changes in gene expression in the striatum (Laviolette and Grace 2006) . In CB 1 knockout mice [CB 1 (−/−)], responses to Δ 9 -THC are absent , and reinforcement effects of alcohol and opioid drugs are dramatically reduced (Hungund et al. 2003; Ledent et al. 1999 ). Moreover, CB 1 antagonism by SR141716 (rimonabant) reduced opioid self-administration and conditioned place preference in rodents Martin et al. 2000) .
In humans, age and sex differences have been reported when the biological and behavioral effects of drugs of abuse were examined (Greenfield et al. 2003; Randall et al. 1999; von Sydow et al. 2001; Young et al. 2002) . These and other studies indicate that the onset and progression to drug addiction and the substances abused differ based on age and sex (Degenhardt et al. 2007) . It also suggests the need to identify the neuromodulator mechanisms that are responsible for these differences.
Recent studies in animals indicate that ablation of the CB 1 receptor causes significant differences in the gene expression of the endogenous opioid peptides, preproenkephalin (PPENK) and preprodynorphin (PPDYN), as well as D 4 dopamine receptors in the striatum of CB 1 (−/−) mice (Gerald et al. 2006; Steiner et al. 1999 ) and reduction of D 2 dopamine receptor binding (Houchi et al. 2005 ). In addition, human genetic variation (polymorphisms) in the cannabinoid, dopamine, and opioid receptor systems are, to varying degrees, linked with neuropathologies including those related to drug addiction (Chakrabarti et al. 2006; Hoenicka et al. 2007; Hopfer et al. 2006; Saxon et al. 2005; van den Wildenberg et al. 2007) . In this present study, the evaluation of gene expression differences in CB 1 (−/−) transgenic mice was furthered by including, in our examination, the primary effects and interactions of sex and age on the gene expression of five members of the opioid receptor system and five dopamine receptor subtypes in the striatum.
Materials and methods

Animals
CB 1 transgenic mice studies Zimmer et al. (1999) generated CB 1 (−/−) mice by replacing the coding region in the mouse CB 1 receptor gene between amino acids 32 and 448 with a PGK-neo cassette to create chimeric mice which were bred with C57BL/6J animals. In the present study, CB 1 (+/+) and CB 1 (−/−) mice were produced by inbreeding the CB 1 (+/−) mice at North Carolina Central University or the University of North Carolina-Chapel Hill. All animals used in this study were treated in accordance with the Guide for the Care and Use of Laboratory Animals (NIH Publications No. 90-23) revised 1996. Animals were anesthetized and decapitated, as approved by institutional Animal Care and Use Committees. Adult mice of both sexes at two different ages [60-90 days (young) and 140-300 days (old)] were used. The number of animals used were males: CB 1 (+/+) young (6-8), old (8-10); CB 1 (−/−) young (7-8), old (5-8) and females: CB 1 (+/+) young (4-5), old (4); CB 1 (−/−) young (4-5), old (3).
Reverse transcription and qPCR
Both striata were dissected free hand from each mouse brain and immediately stored at −80°C until extraction of total RNA. Total RNA was isolated from striata of all mice using Trizol Reagent (Invitrogen) stored at −80°C. RNA was purified for reverse transcription and quantitative realtime polymerase chain reaction (qPCR) using the RNeasy MinElute Cleanup Kit (Qiagen) and registered a 260/ 280 nm absorbance ratio of >2.0.
Total purified RNA (1 μg) was reversed transcribed into complementary DNA (cDNA) using a high-capacity cDNA archive kit (Applied Biosystems). Quantitative real-time PCR was performed using a 7500 real-time PCR system (Applied Biosystems) utilizing the TaqMan gene expression assays specific for 18S (human), opioid peptides (mouse preprodynorphin and preproenkephalin), five dopamine receptor subtypes (mouse D 1 -D 5 ), and three opioid receptors (mouse δ-OR, μ-OR, κ-OR). Gene expression was normalized to 18S cDNA. Relative quantitation of gene expression levels was performed using the Delta Delta C t method (2 -ΔΔCt method; Livak and Schmittgen 2001) .
Statistics and data analysis
Relative expression data from qPCR for each gene examined was tested for normality using the AndersonDarling normality test and for homogeneity of variance in group using Levene's test. If data for a particular gene did not comply with the assumption of normality and/or homogeneity of variance, the relative expression ratios for that gene were subjected to a logarithmic transformation. Both transformed and non-transformed relative gene expression ratios were treated as the response in a general linear model (GLM) univariate analysis of variance (ANOVA). The model utilized a 2×2×2 factorial design by which genotype [CB 1 (+/+), CB 1 (−/−)], sex (male, female), and age (young, old) were fixed (i.e., each factor level represented a discrete value). The factors were crossed such that the main effects (genotype, sex, and age), primary interactions (genotype × sex, genotype × age, and sex × age) and the second-order interaction (genotype × sex × age) could be evaluated. A subsequent pairwise comparison of all means was performed using Tukey-Kramer and Bonferroni multiple comparison tests. To further examine the effect of CB 1 ablation, both transformed and nontransformed data from CB 1 (+/+) and (CB 1 (−/−) mice of the same age and sex were compared using a two-sample t test. For this t test, equal variance was not assumed. For all data in this study, differences at the p ≤ 0.05 level were considered significant. All statistical calculations and analyses were performed using the MINITAB 13.32 statistical software package (Minitab Inc., State College, PA, USA).
Results
The amount of messenger RNA (mRNA) for eight Gprotein coupled receptors (GPCRs) were examined in striata from young adult male CB 1 (+/+) mice, and the results are presented in Fig. 1 Evaluation of the data in Fig. 2b showed significant differences in PPDYN gene expression due to second-order were performed using RT-qPCR as described in "Materials and methods". Levels of mRNA were quantitated using the Delta Delta C t method (2 -ΔΔCt method; Livak and Schmittgen 2001) , and the results are presented relative to D 1 dopamine receptor subtype mRNA levels in the striatum interactions among genotype, sex, and age [F (1,38) [F (1,38) =3.45, p=0.071]. Unlike PPENK gene expression, which was higher in female over males, there was no main effect due to sex [F (1,38) =0.29, p=0.594] . Therefore, the significant second-order interactions among genotype, sex, and age were due mainly to the effect of age. The primary interaction between genotype and sex appeared to be mainly due to the effect of genotype, and subsequent pairwise comparisons of all means support this interpretation. Post hoc test revealed significantly higher PPDYN gene expression in old over young male mice regardless of genotype (p <0.002) and that CB 1 ablation increased PPDYN gene expression in female mice regardless of age (p<0.001). When young males were evaluated separately, PPDYN gene expression appeared to be reduced in CB 1 (−/−) mice when compared to their CB 1 (+/+) counterparts, and this was confirmed using a two-sample t test (t=3.63, df=9, p=0.006).
Striatal δ-OR and μ-OR gene expression in mice: influence of age and sex
Evaluation of the data from Fig. 3a using a GLM ANOVA revealed significant differences in δ-OR gene expression due to the main effect of age [F (1,40) =14.91, p<0.0005]. Subsequent pairwise comparisons of all means confirmed significantly higher δ-OR gene expression in old over young mice when animals of the same genotype and sex were compared (p<0.05). There were no main effects due to genotype [F (1,40) Data from Fig. 3b were evaluated using a GLM ANOVA, and it showed significant differences in μ-OR gene expression due to second-order interactions among genotype, sex, and age [F (1,37) =9.42, p=0.004] and a significant main effect due to sex [F (1,37) =29.19, p< 0.0005]. Therefore, the interactions among genotype, sex, and age were due mainly to the effects of sex. There were no main effects due to genotype [F (1,37) The influence of CB 1 ablation, sex, and age. a PPENK gene expression, b PPDYN gene expression. Gene expression levels were determined in total RNA extracts from brain striata of young and old adult CB 1 (+/+) [wild-type (WT)] and CB 1 (−/−) [mice with CB 1 receptor ablation (KO)] mice (n=3-10) using RT-qPCR. All data are presented relative to expression levels in young adult male CB 1 (+/+) mice. Data were evaluated using a general linear model (GLM) univariate ANOVA. The model utilized a 2×2×2 factorial design where genotype, sex, and age were fixed. Subsequent differences due to genotype, sex, and age were determined using Tukey-Kramer and Bonferroni multiple comparison tests. In mice of the same age and sex, differences due to genotype (WT vs. KO mice) were also determined using a twosample t test. of all means confirmed significantly higher μ-OR gene expression in female over male mice when expression was examined in mice of the same age and genotype (p<0.002). When CB 1 (+/+) mice were compared to CB 1 (−/−) mice of the same age and sex, using a two-sample t test, a significant increase in μ-OR gene expression was observed in CB 1 (−/−) over CB 1 (+/+) old male mice (t=−2.27, df=9, p=0.05).
In a preliminary study with a limited number of samples, the influence of CB 1 ablation, sex, and age on κ-OR gene expression was evaluated using a GLM ANOVA. The results revealed significant differences in κ-OR gene expression due to the effect of age [F (1,25) =5.95, p=0.022], and there were significant interactions between genotype and sex [F (1,25) =4.25, p=0.05] . No other interaction between groups (genotype and age; sex and age; genotype, sex, and age) were observed. Subsequent pairwise comparisons of all means using Tukey-Kramer and Bonferroni multiple comparison tests revealed significantly higher κ-OR gene expression in old over young male mice (p=0.043). Dopamine D 1 -like receptor subtype gene expression: influence of CB 1 ablation, sex, and age D 1 -like receptor (D 1 and D 5 ) gene expression in striata isolated from CB 1 (+/+) and CB 1 (−/−) mice were examined in Fig. 4 . Evaluation of the data from Fig. 4a =1.54, p=0.221] . Therefore, the primary interaction between genotype and sex was attributed to the main effect of sex. Subsequent pairwise comparisons revealed significantly higher D 5 dopamine receptor gene expression in female over male young CB 1 (−/−) mice (p<0.03). A two-sample t test was used to compare the differences between CB 1 (+/+) and CB 1 (−/−) mice of the same sex and age. The results showed a reduction in receptor gene expression in young male mice (t=4.32, df=10, p=0.002) and an increase in receptor gene expression in young female mice (t=−3.53, df=6, p=0.012) due to CB 1 ablation. Dopamine D 2 -like receptor subtype gene expression: influence of CB 1 ablation, sex and age Evaluation of the data from Fig. 5a indicate that the combined effects of genotype and sex [F (1,41) =5.01, p= 0.031] appeared to influence the main effect of age [F (1,41) = 7.56, p=0.009] to significantly increase D 2 dopamine receptor gene expression in old over young male mice (p<0.006). There were no main effects due to genotype . Gene expression levels were determined in total RNA extracts from brain striata of young and old adult CB 1 (+/+) and CB 1 (-/-) mice (n=3-10) and subjected to analysis as described in Fig. 2 Discussion CB 1 receptor ablation in mice produces early mortality and deterioration in cognitive, memory, and motor function which has been characterized as "accelerated aging" (Bilkei-Gorzo et al. 2005; Steiner et al. 1999; Zimmer et al. 1999 ). Some of these phenotypic deficits involve neostriatal regulation, including increased immobility or catalepsy, hypoactivity, decline in skills learning, deficit social memory, and reduced operant responding to reinforcing stimuli (Bilkei-Gorzo et al. 2005; Holter et al. 2005) . The reduced operant response reflects reduced incentive in that CB 1 (−/−) mice are characterized by a genotypic reduction in the consumption of sweet foods and alcohol and selfadministration of reinforcing substances such as morphine (Cossu et al. 2001; Houchi et al. 2005; Hungund et al. 2003; Ledent et al. 1999; Martin et al. 2000; Sanchis-Segura et al. 2004 ). This behavioral phenotype has been linked with neurochemical differences in CB 1 (−/−) striatal tissue, including differences in the expression of substance P, opioid peptides, and enzymes that synthesize neurotransmitters (Steiner et al. 1999) . Furthermore, reinforcing substances, which characteristically are accompanied by increased dopamine in the nucleus accumbens, fail to evoke dopamine accumulation in CB 1 (−/−) mice (Hungund et al. 2003; Mascia et al. 1999) .
The goal of the present study was to extend our knowledge of the effects of CB 1 receptor ablation on gene expression for members of the opioid (δ-OR, μ-OR, PPENK, and PPDYN) and dopamine (D 1 through D 5 receptor) systems in the striatum. This was accomplished by including in our evaluation the influence of the primary effects and interactions of sex and age on differences produced in CB 1 transgenic mice. The results, presented in Gene expression levels were determined in total RNA isolated from brain striata of young and old adult CB 1 (+/+) and CB 1 (−/−) mice (n=3-10) and subjected to analysis as described in Fig. 2 Figs. 2, 3, 4, and 5 and summarized in Table 1 , showed genotypically greater expression of striatal opioid peptides and D 3 , D 4 and D 5 dopamine receptors in CB 1 (−/−) compared with CB 1 (+/+) mice. It was striking that these genotypic differences were restricted to females, particularly young adult females.
Age-related differences in gene expression
Age-related differences were observed, particularly in males, in the expression of PPDYN and δ-OR in the opioid receptor system and in D 1 , D 2 , D 3 , and D 4 dopamine receptor expression. Genotypic differences in gene expression were age-related in males for opioid peptide and μ-OR expression and in females for D 3 and D 5 dopamine receptors expression. The effect of age and CB 1 receptor ablation on behavior has been extensively investigated in mice with C57BL/6 and CD1 backgrounds (Bilkei-Gorzo et al. 2005) . In young mice (6-7 weeks), CB 1 (−/−) and CB 1 (+/+) mice perform the same in learning and memory paradigms including skill learning, partner recognition, and operant conditioning. In contrast, mature adult (3-5 months) CB 1 (−/−) perform poorly, but comparable to older (14-17 months) CB 1 (+/+) mice. These studies demonstrate an acceleration of the age-related decrement in cognitive and motor function in CB 1 (−/−) mice. One explanation for these age-related differences may be the sensitivity of neurons to neurotoxicity and the protective nature of endocannabinoids exerted through CB 1 receptors (Veldhuis et al. 2003) . However, it is not clear whether striatal neurons are as vulnerable to neurotoxicity as some areas of the hippocampus.
Significant age-related differences have been observed in the ability of the endocannabinoid system to modulate the intake of reinforcing substances such as ethanol and palatable food. In C57BL/6 mice that are in the same age range as the young adults used in the present study (6-10 weeks), CB 1 (+/+) mice prefer ethanol to a greater extent than do CB 1 (−/−) mice or CB 1 (+/+) mice treated with the CB 1 antagonist SR141716 (Wang et al. 2003) . Greater food intake is also observed in food-restricted juvenile CB 1 (+/+) mice compared with CB 1 (−/−) mice (Di Marzo et al. 2001) or CB 1 (+/+) mice treated with SR141716 (Wang et al. 2003) . Gene expression levels were determined in total RNA isolated from brain striata of young and old adult CB 1 (+/+) and CB 1 (−/−) mice (n=3-10) and subjected to analysis as described in Fig. 2 Juvenile mice have greater ethanol and food intake than old mice (26-48 weeks), and the ethanol and food intake in older adult mice cannot be reduced by SR141716 (Wang et al. 2003) . Therefore, age has significant behavioral consequence when CB 1 receptor activity is modified. Our studies demonstrated several potential neurochemical substrates, in the opioid and dopamine receptor system, which may account for the genotype and age-related differences in motor behaviors and response to reinforcing substances. In previous studies, no differences in anandamide or 2-arachidonoylglycerol content were found in the limbic forebrain of young compared with old mice (Wang et al. 2003) . Similarly, no differences were detected in CB 1 receptor density in young compared with old mice. However, these studies do find twofold greater HU210-stimulated GTPγS binding in limbic forebrain in young versus old mice (Wang et al. 2003) .
Sexual dimorphic effects of cannabinoids
In our study, PPENK and the μ-OR gene expression was greater in young and old adult females compared with males, with no genotypic increase in PPENK occurring in males but a genotypic increase in μ-OR in old adult males. The D 3 and D 5 receptor expression was significantly greater in young adult female CB 1 (−/−) compared with CB 1 (+/+), whereas no such increase was observed with males. In male mice, older adults expressed greater levels of D 2 and D 3 receptors than younger males. One explanation for phenotypic differences in the CB 1 (−/−) might be the developmental perturbations of the lack of cannabinoid receptors during critical stages of neurogenesis. Developmental studies (Rodriguez de Fonseca et al. 1993 ) have previously demonstrated a sexual dimorphic pattern of CB 1 receptors arising in prenatal striata. Prenatal exposure to cannabinoid agonists modifies μ-OR density, and it differs with the sex of the animal (Perez-Rosado et al. 2000; Vela et al. 1998 ), leading to the possibility of differences established before birth in the CB 1 (−/−) genotype that might lead to a sexually dimorphic character when behaviors are tested as adults.
Behaviorally, Tseng and Craft (2001) found that Δ 9 -THC produces greater hypoactivity measures in female compared with male rats. The relatively greater hypolocomotion and catalepsy responses to cannabinoid agonists in females are also observed with 11-OH-THC and CP55940, indicating that the sexual dimorphism is not attributed to 
The (Tseng and Craft 2001) . The catalepsy response is blocked by SR141716, indicating that CB 1 receptors are responsible (Tseng and Craft 2004) . Sexually dimorphic responses in reinforcement behaviors have also been observed. Hungund et al. (2003) report that in a population of young adult C57BL/6 mice (13-15 weeks of age), the female mice consume significantly more alcohol (two-bottle choice test) than males. The ablation of the CB 1 receptor significantly reduces the response in male mice. However, the magnitude of the reduction in females is much greater than males, as consumption of alcohol in both male and female mice does not differ.
Regulation of the dopaminergic and opioid mechanisms in the striatum and nucleus accumbens
The influence of CB 1 receptors on enkephalin-containing neurons in striata has previously been reported. Cannabinoid treatment of rats with the potent agonist CP55940 for 18 days resulted in a robust increment in PPENK mRNA in both the striatum and nucleus accumbens (Manzanares et al. 1998) . This may represent a means by which cannabinoid receptors mediate the activation of opioid receptors . If our observed increases in PPENK in CB1(−/−) mice are also considered, these studies would suggest that the enkephalin-containing neurons are under tonic regulatory control by endocannabinoids. The converse interaction, the influence of enkephalin on the cannabinoid responses, is not as striking, inasmuch as no differences were observed between PPENK (−/−) and WT C57BL/6J mice in the ability of Δ 9 -THC to decrease locomotion or invoke catalepsy . This would indicate that enkephalin-containing neurons are not intrinsic to a pathway that mediates these responses to cannabinoid drugs. Nevertheless, some of the withdrawal effects after chronic Δ 9 -THC treatment might involve enkephalin-containing neurons in the striatum .
The influence of CB 1 receptors on dynorphin-containing neurons in the striatum are beginning to be established. PPDYN(−/−) mice are no different from WT C57BL/6 in the Δ 9 -THC-decreased locomotion response attributed to striatal neurons. However, PPDYN(−/−) mice are characterized by the absence of Δ 9 -THC-induced conditioned place aversion (Zimmer et al. 2001) . This suggests that dynorphin-containing neurons are in the pathway for the Δ 9 -THC dysphoric response. Nor-BNI also blocked Δ 9 -THC conditioned place aversion, indicating that dynorphin is working through κ-OR (Zimmer et al. 2001) . It is not clear whether the striatum is involved in the anxiety and dysphoria due to Δ 9 -THC. The aversive response to kappa opioids was reduced in the CB 1 (−/−) phenotype, indicating that the aversive responses are a coordinated mechanism rather than one that is linearly downstream from the other (Zimmer et al. 2001) . However, limited observations in our present study showed no difference in κ-OR expression due to genotype.
An extensive literature has developed surrounding the interactions between the endocannabinoid and dopaminergic systems in the striatum (Gerdeman et al. 2003; van der Stelt and Di Marzo 2003) . CB 1 receptors are expressed in D 1 -and D 2 -like receptor expressing neurons in the striatum (Hermann et al. 2002) , suggesting a degree of cross-talk between these receptor systems. Indeed, D 2 -like receptors (D 2 , D 3 , and D 4 ) have been shown to be functionally coupled to the endocannabinoid system, as dopamine increased anandamide synthesis and release in dorsal striata, and postsynaptic D 2 receptor stimulation parallels the increase in endocannabinoid in striata (Giuffrida et al. 1999) . In situ hybridization showed that chronic treatment with D 2 antagonists up-regulated CB 1 mRNA in rat caudate-putamen (Mailleux and Vanderhaeghen 1993) . However, D 1 -like (D 1 , D 5 ) receptor activation using the agonist SKF38393 did not exhibit similar effects on the endocannabinoid system (Giuffrida et al. 1999 ).
Influence of D 4 dopamine receptor activity on behavior
Genetic modification of members of the endocannabinoid, opioid, and dopamine receptor systems have been linked to various neuropathologies with behavioral consequences, including those related to drug addiction, attention deficit hyperactivity disorder (ADHD), and bipolar disease (Saxon et al. 2005; Schmidt et al. 2002; Wong et al. 2000) . However, many of these links or associations have been questioned due to conflicts among the published data (Chakrabarti et al. 2006; Helmeste and Tang 2000; Hoenicka et al. 2007; Hopfer et al. 2006; Saxon et al. 2005; van den Wildenberg et al. 2007; Wong et al. 2000) . In the present study, large differences in D 4 dopamine receptor gene expression were detected in CB 1 ablated female mice, but gene expression independent of genotype was a function of age or sex. D 4 receptor expression has specifically been linked to neuropathologies, particularly ADHD, whose relationship to genetic modification of the receptor is currently being considered (Helmeste and Tang 2000; Wong et al. 2000 ). Yet, D 4 -receptor-ablated mice exhibited hyperactivity in open field test, supersensitivity to the locomotor-stimulating effects of ethanol, cocaine and methamphetamine, and elevated synthesis of dopamine and its metabolite 3,4-dihydroxyphenylacetic acid in the caudate-putamen, but not in the nucleus accumbens. These D 4 -receptor-deficient mice were more adept than wild-type mice at complex motor functions as determined by rotarod performance tests. This has been attributed to the elevated dopamine levels (Rubinstein et al. 1997) . Spontaneously hypertensive rats (SHR), considered a suitable rat model for ADHD, are hyperactive in the open field test. In the SHR strain, D 4 dopamine receptor gene expression was reduced in the prefrontal cortex, but not in the striatum (Li et al. 2007) . In an ADHD model induced by lateral ventricle 6-hydroxydopamine injection, wild-type mice developed hyperactivity, but D 4 -receptor-ablated mice did not (Avale et al. 2004 ). D 4 receptor antagonists (i.e., PNU-101387G, L-745,870, and U-101,958 but not S-18126) blocked the hyperactivity in this ADHD mouse model (Avale et al. 2004; Zhang et al. 2001 Zhang et al. , 2002 . Despite these observations, the underlying mechanism(s) are still open to speculation.
A possible resolution to this question may reside in further studies involving CB 1 transgenic mice. CB 1 -deficient mice lack normal dopamine-mediated suppression of PKA activity, mediated by postsynaptic D 4 receptors, which blocks GABA A currents in the globus pallidus (Engler et al. 2006; Shin et al. 2003) . Selective genes in striata, including those for opioid peptides, are influenced by increased cAMP and PKA activation via a cAMP response element binding protein (CREB)-mediated mechanism. Therefore, modulation of CB 1 receptor activity could influence, either directly or indirectly, CREB-mediated mechanisms that affect gene expression that impacts memory, addiction, depression, and anxiety (Carlezon et al. 2005 ).
In conclusion, differences in opioid peptide and in D 3 , D 4 , and D 5 dopamine receptor gene expression, which were greater in females, were observed in striata from CB 1 -ablated mice. Meanwhile, greater differences independent of genotype were observed in the gene expression for PPENK, μ-OR, and D 4 dopamine receptors in females and were also observed in the gene expression for PPDYN, δ-OR, and dopamine receptor subtypes D 2 , D 3 , and D 4 in old males. These significant genotypic, age-dependent, and sexually dimorphic differences in gene expression may contribute to the phenotypic deficit behaviors associated with these genes. They may also contribute to the various behavioral differences that have been observed with these featured groups.
